News

Researchers at The University of Queensland in Australia and Albert Einstein College of Medicine in the US have developed a new statistical method for discovering elusive cancer-promoting genes.

Voting has opened for this year's Queensland Women in STEM Prize.

AIBN is dedicated to advancing the careers of all our researchers.

Our Institute is dedicated to finding solutions to society’s problems; facilitating achievement of gender equality in STEM is an important and necessary part of that vision

University of Queensland Professor Yusuke Yamauchi, in collaboration with researchers from The University of Tokyo has been awarded the first Rio-Tinto Australia-Japan Collaboration Program Grant.

Professor Lianzhou Wang and his colleagues at AIBN are developing artificial leaves to capture CO2 and convert it into carbon-neutral fuels

Researchers from the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) have discovered a unique nano-scaled DNA signature that appears to be common to all cancers.

The University of Queensland and CSIRO are building a new world-class $4.5 million initiative to boost Australia’s synthetic biology capabilities. The promising new venture was officially announced today at Customs House in Brisbane by UQ Vice-Chancellor Professor Peter Høj and CSIRO Executive Director for Environment, Energy and Resources Dr Peter Mayfield.

University of Queensland (UQ) PhD researcher Kevin Koo has won the inaugural Metrohm Australia-New Zealand Young Chemist of the Year award in recognition of his work in developing nanotechnology-based cancer diagnostics.

This week AIBN held its 2018 Three Minute Thesis (3MT) heats. We had two outstanding entrants this year, who gave strong presentations.

Research led by Professor Gordon Xu of the Australian Institute for Bioengineering and Nanotechnology (AIBN) has shown that clay nanoparticles can significantly boost immune responses as vaccine adjuvants.

New research from the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland has brought us a step closer to understanding how protein clumps called amyloid plaques contribute to the death of brain cells in Alzheimer’s disease.

AIBN is delighted to welcome Professor Joe Shapter, a world renowned leader in surface science and scanning probe microscopy.

Increased energy – or metabolic use – in patients with motor neurone disease (MND) has been linked to faster disease progression and reduced lifespan, according to University of Queensland researchers.

AIBN researchers have topped the nation in the 2018 round of Human Frontier Science Program research funding awards.

UQ Researchers have developed a new nanotechnology to monitor drug resistance and diversity of individual cancer cells circulating in the body.

Researchers have developed a new approach to delivering DNA into cells using spikey silica nanoparticles. These nanoparticles transport the genetic cargo across the cell wall while protecting it from degradation.

Professor Linda Lua, Director of the Protein Expression Facility housed at AIBN, is developing a new vaccine candidate for avian influenza.

Researchers have developed a cost-effective method of converting agricultural waste biomass into commercially valuable chemicals for food production, pharmaceuticals, agriculture and other industries.

Trau group researchers are using nanotechnology for fabrication-free disease biomarker detection within a fluidic droplet. The “lab-in-a-drop” system can be extremely useful for the detection of disease nucleic acid biomarkers.

In early December the Centre for Personalised Nanomedicine at AIBN held an information evening on how breast cancer research in Queensland is making an impact. During the event So Brave founder, Rachelle Panitz, presented Professor Matt Trau with a $35,000 cheque to support research intro breast cancer.